CRISPR-Based Gene Editing in Acinetobacter baumannii to Combat Antimicrobial Resistance

Abstract

Antimicrobial resistance (AMR) poses a significant threat to the health, social, environment, and economic sectors on a global scale and requires serious attention to addressing this issue. Acinetobacter baumannii was given top priority among infectious bacteria because of its extensive resistance to nearly all antibiotic classes and treatment options. Carbapenem-resistant A. baumannii is classified as one of the critical-priority pathogens on the World Health Organization (WHO) priority list of antibiotic-resistant bacteria for effective drug development. Although available genetic manipulation approaches are successful in A. baumannii laboratory strains, they are limited when employed on newly acquired clinical strains since such strains have higher levels of AMR than those used to select them for genetic manipulation. Recently, the CRISPR-Cas (Clustered regularly interspaced short palindromic repeats/CRISPR-associated protein) system has emerged as one of the most effective, efficient, and precise methods of genome editing and offers target-specific gene editing of AMR genes in a specific bacterial strain. CRISPR-based genome editing has been successfully applied in various bacterial strains to combat AMR; however, this strategy has not yet been extensively explored in A. baumannii. This review provides detailed insight into the progress, current scenario, and future potential of CRISPR-Cas usage for AMR-related gene manipulation in A. baumannii.

Understanding the biofilm development of Acinetobacter baumannii and novel strategies to combat infection

“…In this context, the innovative use of CRISPR-Cas9 technology allowed for the design of phages by modifying the tail protein gene sequence. This modification increases the phage's efficacy and specificity in targeting bacterial cells during lysis [115].…”

Molecular Aspects of the Functioning of Pathogenic Bacteria Biofilm Based on Quorum Sensing (QS) Signal-Response System and Innovative Non-Antibiotic Strategies for Their Elimination

“…Each CRISPR/Cas system has a specific protein composition for expression, interference, and adaptation [ 394 , 395 , 400 ]. Class 1 comprises three types (I, III, and IV) and sixteen subtypes, whereas Class 2 includes three types (II, V, and VI) and seventeen subtypes [ 401 , 402 ]. The Class 1 CRISPR/Cas system takes on interference through the use of a multi-Cas effector protein complex, whereas Class 2 utilises a single effector protein responsible for the identification and cleavage of the target sequence [ 403 ].…”

2-Pyridinecarboxaldehyde-Modified Chitosan–Silver Complexes: Optimized Preparation, Characterization, and Antibacterial Activity

“…The invention and use of antimicrobial agents and antibiotics have lowered the morbidity and lethality of infectious diseases caused by microorganisms in humans. Unfortunately, many broad-spectrum antibiotics clinically used to prevent and control infections have been misused over time, resulting in the emergence of drug-resistant pathogens [2]. Therefore, antibiotic-free, broad-spectrum, and highly efficient antibacterial materials are urgently required.…”